In univariate regression analyses, serum levels of Gal-9 at 24 h post-MI (5.69 ± 1.80 ng/mL) were associated with an increased infarct size (β = −0.258, p = 0.006), and serum levels of HMGB-1 (24.56 ± 8.53 ng/mL) and CEACAM1 (19.69 ± 10.28 ng/mL) were associated with lower LVEF (β = −0.210, p = 0.026 and β = −0.189, p = 0.040, respectively) 4 months post-MI (Table 1). Here, LGALS9 is linked to myocardial infarction.